{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:09:01Z","timestamp":1772240941869,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tactile Medical"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Head and neck cancer (HNC) will be diagnosed in approximately 54,000 Americans in 2022 with more than 11,000 dying as a result. The treatment of HNC often involves aggressive multimodal therapy including surgery, radiotherapy, and systemic therapy. HNC and its treatments are associated with multiple painful and function-limiting neuromusculoskeletal and visceral long-term and late effects. Among these is head and neck lymphedema (HNL), the abnormal accumulation of protein rich fluid, in as many as 90% of survivors. Though HNL is common and potentially contributory to other function-limiting issues in this population, it is notoriously understudied, underrecognized, underdiagnosed, and undertreated. This study seeks to determine the incidence of HNC-related lymphedema diagnosis and treatment in a large US healthcare claims repository database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective observational cohort design and data from an integrated US healthcare claims repository\u2014the IBM MarketScan Commercial Claims and Encounters (CCAE) and Medicare Supplemental and Coordination of Benefits (MDCR) Databases spanning the period April 1, 2012 through March 31, 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 16,654 HNC patients eligible for evaluation, 1,082 (6.5%) with a diagnosis of lymphedema were identified based on eligibility criteria. Of the 521 HNC patients evaluated for lymphedema treatment, 417 (80.0%) patients received 1.5 courses of MLD, 71 (13.6%) patients were prescribed compression garments, and 45 (8.6%) patients received an advanced pneumatic compression device.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HNL in this population of HNC survivors was underdiagnosed and treated compared with contemporary assessments HNL incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-023-07698-3","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T03:04:09Z","timestamp":1679540649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Under recognition and treatment of lymphedema in head and neck cancer survivors \u2013 a database study"],"prefix":"10.1007","volume":"31","author":[{"given":"Michael D.","family":"Stubblefield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Weycker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"7698_CR1","unstructured":"Cancer Facts and Figures (2022) https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2022\/2022-cancer-facts-and-figures.pdf. Accessed 26 Jul\u00a02022"},{"key":"7698_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/14737140.7.7.1043","volume":"7","author":"BA Murphy","year":"2007","unstructured":"Murphy BA, Gilbert J, Ridner SH (2007) Systemic and global toxicities of head and neck treatment. Expert Rev Anticancer Ther 7:1043\u20131053","journal-title":"Expert Rev Anticancer Ther"},{"key":"7698_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR (2022) HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 19:306\u2013327","journal-title":"Nat Rev Clin Oncol"},{"key":"7698_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3322\/caac.21343","volume":"66","author":"EE Cohen","year":"2016","unstructured":"Cohen EE, LaMonte SJ, Erb NL et al (2016) American cancer society head and neck cancer survivorship care guideline. CA Cancer J Clin 66:203\u2013239","journal-title":"CA Cancer J Clin"},{"key":"7698_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11912-022-01227-x","volume":"24","author":"SC Parke","year":"2022","unstructured":"Parke SC, Langelier DM, Cheng JT, Kline-Quiroz C, Stubblefield MD (2022) State of rehabilitation research in the head and neck cancer population: Functional impact vs. impairment-focused outcomes. Curr Oncol Rep 24:517\u2013532","journal-title":"Curr Oncol Rep"},{"key":"7698_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fphys.2020.00137","volume":"11","author":"SH Azhar","year":"2020","unstructured":"Azhar SH, Lim HY, Tan BK, Angeli V (2020) The unresolved pathophysiology of lymphedema. Front Physiol 11:137","journal-title":"Front Physiol"},{"key":"7698_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/obr.12565","volume":"18","author":"F Cucchi","year":"2017","unstructured":"Cucchi F, Rossmeislova L, Simonsen L, Jensen MR, B\u00fclow J (2017) A vicious circle in chronic lymphoedema pathophysiology? An adipocentric view. Obes Rev 18:1159\u20131169","journal-title":"Obes Rev"},{"key":"7698_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/lrb.2016.0001","volume":"14","author":"SH Ridner","year":"2016","unstructured":"Ridner SH, Dietrich MS, Niermann K, Cmelak A, Mannion K, Murphy B (2016) A prospective study of the lymphedema and fibrosis continuum in patients with head and neck cancer. Lymphat Res Biol 14:198\u2013205","journal-title":"Lymphat Res Biol"},{"key":"7698_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpainsymman.2011.03.019","volume":"43","author":"J Deng","year":"2012","unstructured":"Deng J, Ridner SH, Dietrich MS et al (2012) Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage 43:244\u2013252","journal-title":"J Pain Symptom Manage"},{"key":"7698_CR10","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1002\/hed.26394","volume":"42","author":"C Jeans","year":"2020","unstructured":"Jeans C, Brown B, Ward EC et al (2020) Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers. Head Neck 42:3364\u20133374","journal-title":"Head Neck"},{"key":"7698_CR11","doi-asserted-by":"publisher","first-page":"104856","DOI":"10.1016\/j.oraloncology.2020.104856","volume":"109","author":"S Tribius","year":"2020","unstructured":"Tribius S, Pazdyka H, Tennstedt P et al (2020) Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy- results of a longitudinal study. Oral Oncol 109:104856","journal-title":"Oral Oncol"},{"key":"7698_CR12","doi-asserted-by":"crossref","unstructured":"Fadhil M, Singh R, Havas T, Jacobson I (2022) Systematic review of head and neck lymphedema assessment. Head Neck 44(10):2301\u20132315","DOI":"10.1002\/hed.27136"},{"key":"7698_CR13","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1188\/11.ONF.E1-E10","volume":"38","author":"J Deng","year":"2011","unstructured":"Deng J, Ridner SH, Murphy BA (2011) Lymphedema in patients with head and neck cancer. Oncol Nurs Forum 38:E1\u2013E10","journal-title":"Oncol Nurs Forum"},{"key":"7698_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semradonc.2008.09.007","volume":"19","author":"BA Murphy","year":"2009","unstructured":"Murphy BA, Gilbert J (2009) Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol 19:35\u201342","journal-title":"Semin Radiat Oncol"},{"key":"7698_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pmr.2016.08.003","volume":"28","author":"MD Stubblefield","year":"2017","unstructured":"Stubblefield MD (2017) Clinical evaluation and management of radiation fibrosis syndrome. Phys Med Rehabil Clin N Am 28:89\u2013100","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"7698_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MOO.0b013e3283393799","volume":"18","author":"BG Smith","year":"2010","unstructured":"Smith BG, Lewin JS (2010) Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 18:153\u2013158","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"7698_CR17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/hed.23084","volume":"35","author":"J Deng","year":"2013","unstructured":"Deng J, Murphy BA, Dietrich MS et al (2013) Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Head Neck 35:1026\u20131035","journal-title":"Head Neck"},{"key":"7698_CR18","doi-asserted-by":"publisher","DOI":"10.1891\/9780826121646","volume-title":"Cancer rehabilitation - principles and practice","author":"MD Stubblefield","year":"2018","unstructured":"Stubblefield MD (2018) Cancer rehabilitation - principles and practice, 2nd edn. Demos Medical, New York","edition":"2"},{"key":"7698_CR19","doi-asserted-by":"publisher","first-page":"e12894","DOI":"10.1111\/ecc.12894","volume":"28","author":"C Jeans","year":"2019","unstructured":"Jeans C, Ward EC, Cartmill B et al (2019) Patient perceptions of living with head and neck lymphoedema and the impacts to swallowing, voice and speech function. Eur J Cancer Care (Engl) 28:e12894","journal-title":"Eur J Cancer Care (Engl)"},{"key":"7698_CR20","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cam4.691","volume":"5","author":"C Shah","year":"2016","unstructured":"Shah C, Arthur DW, Wazer D, Khan A, Ridner S, Vicini F (2016) The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review. Cancer Med 5:1154\u20131162","journal-title":"Cancer Med"},{"key":"7698_CR21","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112:2809\u20132819","journal-title":"Cancer"},{"key":"7698_CR22","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/hed.26110","volume":"42","author":"C Guti\u00e9rrez","year":"2020","unstructured":"Guti\u00e9rrez C, Mayrovitz HN, Naqvi SHS, Karni RJ (2020) Longitudinal effects of a novel advanced pneumatic compression device on patient-reported outcomes in the management of cancer-related head and neck lymphedema: A preliminary report. Head Neck 42:1791\u20131799","journal-title":"Head Neck"},{"key":"7698_CR23","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1245\/s10434-019-07344-5","volume":"26","author":"SH Ridner","year":"2019","unstructured":"Ridner SH, Dietrich MS, Cowher MS et al (2019) A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: Interim analysis. Ann Surg Oncol 26:3250\u20133259","journal-title":"Ann Surg Oncol"},{"key":"7698_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/mrm.25649","volume":"75","author":"MJ Donahue","year":"2016","unstructured":"Donahue MJ, Donahue PCM, Rane S et al (2016) Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI. Magn Reson Med 75:345\u2013355","journal-title":"Magn Reson Med"},{"key":"7698_CR25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/0284186X.2022.2081932","volume":"61","author":"KY Blom","year":"2022","unstructured":"Blom KY, Johansson KI, Nilsson-Wikmar LB, Brog\u00e5rdh CB (2022) Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial. Acta Oncol 61:897\u2013905","journal-title":"Acta Oncol"},{"key":"7698_CR26","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2835::AID-CNCR36>3.0.CO;2-V","volume":"83","author":"O Leduc","year":"1998","unstructured":"Leduc O, Leduc A, Bourgeois P, Belgrado JP (1998) The physical treatment of upper limb edema. Cancer 83:2835\u20132839","journal-title":"Cancer"},{"key":"7698_CR27","doi-asserted-by":"crossref","unstructured":"Deng J, Wulff-Burchfield EM, Murphy BA (2019) Late soft tissue complications of head and neck cancer therapy: lymphedema and fibrosis. JNCI Monographs\u00a02019(53):lgz005","DOI":"10.1093\/jncimonographs\/lgz005"},{"key":"7698_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/0194599818823180","volume":"160","author":"C Gutierrez","year":"2019","unstructured":"Gutierrez C, Karni RJ, Naqvi S et al (2019) Head and neck lymphedema: treatment response to single and multiple sessions of advanced pneumatic compression therapy. Otolaryngol Head Neck Surg 160:622\u2013626","journal-title":"Otolaryngol Head Neck Surg"},{"key":"7698_CR29","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez C, Mayrovitz HN, Naqvi SHS, Karni RJ (2020) Longitudinal effects of a novel advanced pneumatic compression device on patient\u2010reported outcomes in the management of cancer\u2010related head and neck lymphedema: A preliminary report. Head Neck 42(8):1791\u20131799","DOI":"10.1002\/hed.26110"}],"updated-by":[{"DOI":"10.1007\/s00520-023-07809-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000}}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07698-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07698-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07698-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T02:06:17Z","timestamp":1684289177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07698-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["7698"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07698-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2256851\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00520-023-07809-0","URL":"https:\/\/doi.org\/10.1007\/s00520-023-07809-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Michael Stubblefield is a consultant to Tactile Medical.Derek Weycker received consultative reimbursement from Tactile Medical for his independent performance of the health economic analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}